MEDWELLAI, INC.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $594.8K | $0 | $3.9M | $6.6M | $1.9M | $454.2K | $279.1K | $306.4K |
| Cost of Revenue | — | $3.9M | $2.7M | $3.9M | $920.4K | $996.4K | $1.0M | $237.8K |
| Gross Profit | — | $-3.9M | $-2.4M | $2.7M | $931.0K | $-542.2K | $-726.3K | $68.6K |
| Gross Margin | — | — | -63.0% | 40.9% | 50.3% | -119.4% | -260.2% | 22.4% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $2.6M | $9.3M | $16.0M | $3.2M | $22.6M | $352.4K | $1.8M | $1.3M |
| Operating Income | $-2.8M | $-9.1M | $-25.2M | $-688.0K | $-21.7M | $-1.0M | $-4.6M | $-6.1M |
| Operating Margin | -477.6% | — | -651.6% | -10.5% | -1,170.4% | -223.4% | -1,665.0% | -2,002.4% |
| Interest Expense | $52.2K | $83.0K | $276.9K | $18.3K | $436.0K | $655.2K | $214.4K | $-153.7K |
| Pretax Income | $-2.9M | $-9.2M | $-25.5M | $-565.5K | $-22.4M | $-1.1M | $-9.5M | $-5.6M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — |
| Net Income | $-3.6M | $-11.5M | $-25.5M | $-565.5K | $-22.4M | $-1.1M | $-9.5M | $-5.6M |
| Net Margin | -606.5% | — | -659.1% | -8.6% | -1,211.7% | -238.2% | -3,408.0% | -1,820.3% |
| EPS (Basic) | $-0.49 | $-2.72 | $-11.98 | $-0.01 | $-0.16 | $-0.02 | $-0.70 | $-0.67 |
| EPS (Diluted) | $-0.49 | $-2.72 | $-11.98 | — | $-0.16 | $-0.02 | $-0.70 | $-0.67 |
| Shares Outstanding (Basic) | 6.2M | 4.4M | 2.2M | 204.7M | 146.0M | 116.5M | 39.1M | 9.9M |
| Shares Outstanding (Diluted) | 6.2M | 4.4M | 2.2M | 204.7M | 146.0M | 116.5M | 39.1M | 9.9M |
| Dividends Per Share | — | — | — | — | — | — | — | — |